Back to HALO
Daiwa Securities Group Inc. → HALO
Daiwa Securities Group Inc. HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
7
Latest value
$3M
Q3 2026
Peak value
$3M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $952K |
| Q3 2025 | $27K |
| Q4 2025 | $1.3M |
| Q4 2025 | $23K |
| Q1 2026 | $1.5M |
| Q2 2026 | $2M |
| Q3 2026 | $3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3M | 27.6K | — | — |
| Q2 2026 | $2M | 25.7K | — | — |
| Q1 2026 | $1.5M | 23.0K | — | — |
| Q4 2025 | $23K | 349 | — | — |
| Q4 2025 | $1.3M | 19.0K | — | — |
| Q3 2025 | $27K | 367 | — | — |
| Q3 2025 | $952K | 13.0K | — | — |
Other funds holding HALO
$545.3M
$405.4M
$405.4M
$319.1M
$251.9M
$236.6M
$176.7M
$148.6M